Export 68 results:
Sort by: Author Title Type [ Year  (Desc)]
Esmat, G., and M. E. Raziky, "Cirrhosis: A Practical Guide to Management:changing outcome with antiviral or antifibrotic therapies", Cirrhosis: A practical guide to management, New Jersey, John Wiley & Sons Ltd., 2015.
•, A. H. K. A. M. E. - R. •M. E. - S. A. E. M. K. A. H. K. • • • •, "Diffusion-weighted MRI and fibroscan vs. Histopathology for assessment of liver fibrosis in chronic HCV patients: (Pilot study)", Egyptian Journal of Radiology and Nuclear Medicine, vol. Mar , 2015.
El Raziky, M, E. y A, Said SE, Abdelatty S, E. A. W, T. O, G. E. H., and M. M., "IP-10 Serum Level in Chronic Hepatitis C Virus Patients: Relation to Fibrosis and Response to Combined Interferon/Ribavirin Therapy.", J Interferon Cytokine Res. , vol. Aug;35(8):6, pp. 49-5, 2015.
GAMAL ESMAT, M. D., and M. E. Raziky, "Text of Hepologoshoenterology Part1 HEPATOLOGY Chapter III: Hepatitis C Virus (HCV)", Text of Hepologoshoenterology Part1 HEPATOLOGY, cairo, Atlas Publishing & Informative Production S.A.E, 2015.
Raziky, M. E., D. Attia, W. elakel, O. Shaker, H. Khatab, S. Abdo, A. Elsharkawy, and G. Esmat, "Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment", Arab Journal of Gastroenterology , vol. 14 , pp. 94–98 , 2013.
Raziky, O. S. A. E. - S. S. F. A. Z. •S. M. M. E. • • • •, "Osteopontin gene polymorphisms as predictors for the efficacy of interferon therapy in chronic hepatitis C Egyptian patients with genotype 4", Cell Biochemistry and Function, vol. Feb, 2013.